H%3A%2Fppseq-papers%2Fone-sample-expansion-cohort%2Fcode%2Fatezolizumab-sim-study-report.Rmd="F646BB31"
H%3A%2Fppseq-papers%2Fone-sample-expansion-cohort%2Fcode%2Fppseq-one-sample-paper-code.R="09E64309"
H%3A%2Fppseq-papers%2Fone-sample-expansion-cohort%2Fcode%2Fppseq_one_sample_expansion_server_script.R="661FE74F"
H%3A%2Fppseq-papers%2Ftwo-sample%2Ftwo-sample-decision-rule-results.R="E8A8978D"
H%3A%2Ftalks%2Fcleveland-r-gtsummary%2F01-background.Rmd="155FA801"
H%3A%2Ftalks%2Fcleveland-r-gtsummary%2F09-summary.Rmd="14B310A5"
H%3A%2Ftalks%2Fcleveland-r-gtsummary%2Findex.Rmd="229A68D6"
H%3A%2Ftalks%2Frmedicine2021%2F.gitignore="86503F47"
H%3A%2Ftalks%2Frmedicine2021%2F01-background.Rmd="5A47EC88"
H%3A%2Ftalks%2Frmedicine2021%2F02-pp.Rmd="43284DDF"
H%3A%2Ftalks%2Frmedicine2021%2F03-package.Rmd="A46AA66A"
H%3A%2Ftalks%2Frmedicine2021%2Fcustom.css="717877B0"
H%3A%2Ftalks%2Frmedicine2021%2Findex.Rmd="BBE432E7"
H%3A%2Ftalks%2Frmedicine2021%2Fxaringan-themer.css="F287E329"
